102 related articles for article (PubMed ID: 2880412)
1. Plasma somatostatin response in normal and gastrectomized subjects.
Wasada T; Kodama Y; Inoue K; Hisatomi A; Sako Y; Ibayashi H
Tohoku J Exp Med; 1986 Oct; 150(2):181-8. PubMed ID: 2880412
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
Wasada T; Howard B; Dobbs RE; Unger RH
J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
[TBL] [Abstract][Full Text] [Related]
3. Regulation of somatostatin secretion in man: study of the role of free fatty acids and ketone bodies.
Beylot M; Chayvialle JA; Riou JP; Souquet JC; Sautot G; Cohen R; Mornex R
Metabolism; 1984 Nov; 33(11):988-93. PubMed ID: 6149447
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography.
Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Imura H
Diabetes; 1981 Jun; 30(6):471-4. PubMed ID: 6112180
[TBL] [Abstract][Full Text] [Related]
6. High plasma free fatty acid levels contribute to the hypersomatostatinemia of insulin deficiency.
Wasada T; Howard B; McCorkle K; Harris V; Unger RH
Diabetes; 1981 Apr; 30(4):358-61. PubMed ID: 6110603
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal gastropancreatic modulations for the release of somatostatin-like immunoreactivity, glucagon, and insulin in the rat.
Marre M; Miller J; Helman AM; Assan R
Diabetes; 1983 Aug; 32(8):768-73. PubMed ID: 6347773
[TBL] [Abstract][Full Text] [Related]
8. Regulation of peripheral plasma somatostatin like immunoreactivity in type I diabetes: role of the degree of metabolic control.
Beylot M; Chayvialle JA; Rebattu B; Sautot G; Cohen R; Riou JP; Mornex R
Diabete Metab; 1986 Feb; 12(1):39-44. PubMed ID: 3516750
[TBL] [Abstract][Full Text] [Related]
9. Effect of fatty acids on glucose production and utilization in man.
Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
[TBL] [Abstract][Full Text] [Related]
10. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
Itoh M; Hirooka Y; Nihei N
Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
[TBL] [Abstract][Full Text] [Related]
12. Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men.
Peracchi M; Carola F; Cavagnini F; Benti R; Bareggi B; Baccalaro G; Basilisco G
J Endocrinol Invest; 1998 Jan; 21(1):20-3. PubMed ID: 9633018
[TBL] [Abstract][Full Text] [Related]
13. Plasma somatostatin-like immunoreactivity responses to a mixed meal and the heterogeneity in healthy and non-insulin-dependent (NIDDM) diabetics.
Miyazaki K; Funakoshi A; Ibayashi H
Endocrinol Jpn; 1986 Feb; 33(1):51-9. PubMed ID: 2873028
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
Berelowitz M; Kronheim S; Pimstone B; Shapiro B
J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
[TBL] [Abstract][Full Text] [Related]
16. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
[TBL] [Abstract][Full Text] [Related]
17. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
Gutniak M; Grill V; Wiechel KL; Efendić S
Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
[TBL] [Abstract][Full Text] [Related]
18. Plasma Somatostatin-like immunoreactivity in chemically sympathectomized dogs.
Schusdziarra V; Rouiller D; Harris V; Dey R; Unger RH
Horm Metab Res; 1980 Dec; 12(12):656-60. PubMed ID: 6110628
[TBL] [Abstract][Full Text] [Related]
19. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.
Colturi TJ; Unger RH; Feldman M
J Clin Invest; 1984 Aug; 74(2):417-23. PubMed ID: 6146638
[TBL] [Abstract][Full Text] [Related]
20. Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance.
Zancanaro C; Cigolini M; Bonora E; Moghetti P; Cacciatori V; Querena M; Muggeo M
Int J Obes; 1990 Jul; 14(7):551-7. PubMed ID: 1977721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
